- Home
- CODA vs ANIX Comparison
CODA vs ANIX Comparison
Compare CODA & ANIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CODA
- ANIX
- Stock Information
- Founded
- CODA 1994
- ANIX 1982
- Country
- CODA United States
- ANIX United States
- Employees
- CODA N/A
- ANIX N/A
- Industry
- CODA Industrial Machinery/Components
- ANIX Biotechnology: Pharmaceutical Preparations
- Sector
- CODA Industrials
- ANIX Health Care
- Exchange
- CODA Nasdaq
- ANIX Nasdaq
- Market Cap
- CODA 88.7M
- ANIX 108.9M
- IPO Year
- CODA N/A
- ANIX 1987
- Fundamental
- Price
- CODA $8.25
- ANIX $3.18
- Analyst Decision
- CODA Strong Buy
- ANIX Strong Buy
- Analyst Count
- CODA 1
- ANIX 3
- Target Price
- CODA $11.00
- ANIX $9.00
- AVG Volume (30 Days)
- CODA 59.8K
- ANIX 130.6K
- Earning Date
- CODA 06-16-2025
- ANIX 09-05-2025
- Dividend Yield
- CODA N/A
- ANIX N/A
- EPS Growth
- CODA 21.86
- ANIX N/A
- EPS
- CODA 0.30
- ANIX N/A
- Revenue
- CODA $22,758,966.00
- ANIX N/A
- Revenue This Year
- CODA $11.64
- ANIX N/A
- Revenue Next Year
- CODA $14.53
- ANIX N/A
- P/E Ratio
- CODA $26.99
- ANIX N/A
- Revenue Growth
- CODA 24.78
- ANIX N/A
- 52 Week Low
- CODA $5.76
- ANIX $2.07
- 52 Week High
- CODA $9.89
- ANIX $4.20
- Technical
- Relative Strength Index (RSI)
- CODA 57.37
- ANIX 48.32
- Support Level
- CODA $7.81
- ANIX $3.18
- Resistance Level
- CODA $8.50
- ANIX $3.24
- Average True Range (ATR)
- CODA 0.41
- ANIX 0.16
- MACD
- CODA -0.01
- ANIX -0.05
- Stochastic Oscillator
- CODA 63.45
- ANIX 15.56
About CODA Coda Octopus Group Inc. Common stock
Coda Octopus Group Inc develops underwater technologies and equipment for imaging, mapping defense, and survey applications. The company's operations are organized into two reportable segments: the Products Segment (Marine Technology Business serving the subsea market and PAL, which sells other products (acoustic hydrophones and acoustic materials to a different market); and the Services Segment (Marine Engineering Business). Its geographical segments are the Americas, Europe, Australia/Asia, and the Middle East/Africa. The majority of revenue is derived from the Products segment.
About ANIX Anixa Biosciences Inc.
Anixa Biosciences Inc a cancer-focused biotechnology company, develops vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.